ATP-sensitive potassium channel in pancreatic beta cell membrane (KATP channel (pancreatic beta cell))

The ATP-sensitive potassium channel in pancreatic beta cells is a hetero-octameric complex composed of four pore-forming Kir6.2 subunits and four regulatory SUR1 subunits (an ABC transporter family protein)[1][2][3][4]. It translates intracellular metabolic cues (ATP/ADP ratio) into changes in membrane potential, thereby controlling insulin release in response to blood glucose levels[1][2][3][6]. ATP binding inhibits channel activity (leading to cell depolarization and insulin secretion), while Mg-ADP stimulates channel opening (hyperpolarizing the membrane and inhibiting secretion)[1][2]. Mutations in the genes encoding Kir6.2 (KCNJ11) or SUR1 (ABCC8) cause rare forms of diabetes or congenital hyperinsulinism[4]. The channel is targeted by several anti-diabetic drugs (sulfonylureas, meglitinides), which modulate insulin secretion by inhibiting or activating channel activity[4]. Therapeutic targeting carries risk of hypoglycemia, especially in channel-defective patients[4]. The KATP channel’s pivotal role in beta cell function makes it a key biomarker and intervention point in diabetes treatment.

Other names

KATP channelPancreatic KATP channelInward rectifier potassium channel (Kir6.2/SUR1)Kir6.2/SUR1 channel

Sulfonylureas and meglitinides: block the KATP channel (via SUR1 subunit), depolarize the beta cell membrane, promote calcium influx, and stimulate insulin secretion Diazoxide: activates (opens) the KATP channel, hyperpolarizes the membrane and inhibits insulin secretion